Lyra Therapeutics (LYRA) Income Statement (2019 - 2025)
Income Statement report data from Mar 31, 2019 to Dec 31, 2025 for Lyra Therapeutics (LYRA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||
Total Revenue | 10K (-66.67%) | 30K (-83.33%) | 180K (0.00%) | 180K (-14.29%) | 210K (+5.00%) | 200K (-66.67%) | 600K (+13.21%) | 530K (+253.33%) | 150K (-72.22%) | 540K (+17.39%) | 460K (+12.20%) | 410K (+13.89%) | 360K (-32.08%) | 530K (+12.77%) | 470K (+4600.00%) | 10K | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||||||||
Research And Development | 4.38M (+8.15%) | 4.05M (-20.74%) | 5.11M (+4.71%) | 4.88M (-23.27%) | 6.36M (+7.80%) | 5.90M (-55.51%) | 13M (-27.30%) | 18M (+48.66%) | 12M (-0.81%) | 12M (+14.54%) | 11M (-14.29%) | 13M (+25.37%) | 10M (-6.86%) | 11M (+26.79%) | 8.51M (+20.20%) | 7.08M (-5.73%) | 7.51M (+57.44%) | 4.77M (+27.54%) | 3.74M (+0.81%) | 3.71M (+76.67%) | 2.10M (-29.05%) | 2.96M (-1.66%) | 3.01M (+5.99%) | 2.84M (-16.96%) | 3.42M (+23.91%) | 2.76M |
Selling General And Administrative | 2.54M (+13.39%) | 2.24M (-36.00%) | 3.50M (+7.36%) | 3.26M (-9.70%) | 3.61M (-8.14%) | 3.93M (-23.54%) | 5.14M (-11.68%) | 5.82M (+33.49%) | 4.36M (-12.80%) | 5.00M (+9.41%) | 4.57M (-10.92%) | 5.13M (-0.19%) | 5.14M (+24.46%) | 4.13M (+6.17%) | 3.89M (-3.23%) | 4.02M (+12.92%) | 3.56M (+16.34%) | 3.06M (-7.55%) | 3.31M (+24.91%) | 2.65M (+8.61%) | 2.44M (+90.63%) | 1.28M (-7.25%) | 1.38M (-0.72%) | 1.39M (+59.77%) | 870K (+1.16%) | 860K |
Operating Expenses | 7.13M (+13.90%) | 6.26M (-30.52%) | 9.01M (-0.11%) | 9.02M (-22.38%) | 12M (-8.07%) | 13M (-74.50%) | 50M (+106.03%) | 24M (+44.77%) | 17M (-4.32%) | 17M (+2.42%) | 17M (-4.29%) | 18M (+16.66%) | 15M (+1.74%) | 15M (+20.50%) | 12M (+11.62%) | 11M (+0.27%) | 11M (+41.38%) | 7.83M (+11.06%) | 7.05M (+10.85%) | 6.36M (+39.78%) | 4.55M (+7.06%) | 4.25M (-3.19%) | 4.39M (+3.78%) | 4.23M (-1.17%) | 4.28M (+18.23%) | 3.62M |
Depreciation And Amortization | 30K (-70.00%) | 100K (-50.00%) | 200K (+53.85%) | 130K (-7.14%) | 140K | - | 200K (+42.86%) | 140K | -10.00K | - | - | 280K (-6.67%) | 300K (0.00%) | 300K (+7.14%) | 280K (-30.00%) | 400K (+33.33%) | 300K (+328.57%) | 70K (+75.00%) | 40K (+33.33%) | 30K (+200.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K |
Operating Income | ||||||||||||||||||||||||||
Operating Income | -7.12M (+14.10%) | -6.24M (-29.33%) | -8.83M (-0.11%) | -8.84M (-22.52%) | -11.41M (-8.28%) | -12.44M (-74.60%) | -48.97M (+108.21%) | -23.52M (+42.72%) | -16.48M (-2.08%) | -16.83M (+2.00%) | -16.50M (-4.68%) | -17.31M (+16.72%) | -14.83M (+2.99%) | -14.40M (+20.81%) | -11.92M (+7.58%) | -11.08M (+0.18%) | -11.06M (+41.25%) | -7.83M (+11.06%) | -7.05M (+10.85%) | -6.36M (+40.09%) | -4.54M (+6.82%) | -4.25M (-3.19%) | -4.39M (+3.78%) | -4.23M (-1.17%) | -4.28M (+18.23%) | -3.62M |
Ebit | -7.12M (+14.10%) | -6.24M (-29.33%) | -8.83M (-0.11%) | -8.84M (-22.52%) | -11.41M (-8.28%) | -12.44M (-74.60%) | -48.97M (+108.21%) | -23.52M (+42.72%) | -16.48M (-2.08%) | -16.83M (+2.00%) | -16.50M (-4.68%) | -17.31M (+16.72%) | -14.83M (+2.99%) | -14.40M (+20.81%) | -11.92M (+7.58%) | -11.08M (+0.18%) | -11.06M (+41.25%) | -7.83M (+11.06%) | -7.05M (+10.85%) | -6.36M (+40.09%) | -4.54M (+6.82%) | -4.25M (-3.19%) | -4.39M (+3.78%) | -4.23M (-1.17%) | -4.28M (+18.23%) | -3.62M |
EBITDA | -7.09M (+15.47%) | -6.14M (-28.85%) | -8.63M (-0.92%) | -8.71M (-26.50%) | -11.85M (-0.17%) | -11.87M (-75.66%) | -48.77M (+108.51%) | -23.39M (+25.96%) | -18.57M (+18.81%) | -15.63M (+0.13%) | -15.61M (-8.34%) | -17.03M (+17.21%) | -14.53M (+3.05%) | -14.10M (+21.13%) | -11.64M (+8.99%) | -10.68M (-0.74%) | -10.76M (+38.66%) | -7.76M (+10.70%) | -7.01M (+10.74%) | -6.33M (+39.74%) | -4.53M (+6.84%) | -4.24M (-3.20%) | -4.38M (+3.79%) | -4.22M (-1.40%) | -4.28M (+18.23%) | -3.62M |
Other Income / Expenses | ||||||||||||||||||||||||||
Interest Income | 170K (-34.62%) | 260K (-36.59%) | 410K (+36.67%) | 300K (-31.82%) | 440K (-24.14%) | 580K (-32.56%) | 860K (-21.10%) | 1.09M (-18.66%) | 1.34M (+12.61%) | 1.19M (+32.22%) | 900K (-15.89%) | 1.07M (+1683.33%) | 60K (+100.00%) | 30K (+200.00%) | 10K (-66.67%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (+200.00%) | 10K (-50.00%) | 20K (-50.00%) | 40K (-33.33%) | 60K (-25.00%) | 80K (+100.00%) | 40K |
Net Interest Income | 170K (-34.62%) | 260K (-36.59%) | 410K (+36.67%) | 300K (-31.82%) | 440K (-24.14%) | 580K (-32.56%) | 860K (-21.10%) | 1.09M (-18.66%) | 1.34M (+12.61%) | 1.19M (+32.22%) | 900K (-15.89%) | 1.07M (+1683.33%) | 60K (+100.00%) | 30K (+200.00%) | 10K (-66.67%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (0.00%) | 30K (+200.00%) | 10K (-50.00%) | 20K (-50.00%) | 40K (-33.33%) | 60K (-25.00%) | 80K (+100.00%) | 40K |
Other Non Operating Income | 2.11M (+711.54%) | 260K (-81.29%) | 1.39M (+363.33%) | 300K (-89.83%) | 2.95M (+408.62%) | 580K (-32.56%) | 860K (-21.10%) | 1.09M (-75.78%) | 4.50M (+278.15%) | 1.19M (+32.22%) | 900K (-15.89%) | 1.07M (+1683.33%) | 60K (+100.00%) | 30K (+200.00%) | 10K (-66.67%) | 30K (0.00%) | 30K (0.00%) | 30K (-62.50%) | 80K (+166.67%) | 30K (+200.00%) | 10K (-50.00%) | 20K (-90.48%) | 210K (+250.00%) | 60K (-25.00%) | 80K (+100.00%) | 40K |
Net Income | ||||||||||||||||||||||||||
Income Before Tax | -6.95M (+16.22%) | -5.98M (-19.52%) | -7.43M (-13.00%) | -8.54M (-22.15%) | -10.97M (-7.58%) | -11.87M (-75.33%) | -48.12M (+114.44%) | -22.44M (+48.22%) | -15.14M (-3.13%) | -15.63M (+0.13%) | -15.61M (-3.88%) | -16.24M (+9.95%) | -14.77M (+2.78%) | -14.37M (+20.65%) | -11.91M | - | - | - | - | - | - | - | - | - | - | - |
Income Tax Expense | - | - | - | - | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (-50.00%) | 20K (0.00%) | 20K (+100.00%) | 10K (0.00%) | 10K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -6.95M (+16.22%) | -5.98M (-19.62%) | -7.44M (-12.98%) | -8.55M (-22.13%) | -10.98M (-7.50%) | -11.87M (-75.34%) | -48.13M (+114.39%) | -22.45M (+48.09%) | -15.16M (-3.13%) | -15.65M (+0.19%) | -15.62M (-3.88%) | -16.25M (+10.02%) | -14.77M (+2.78%) | -14.37M (+20.65%) | -11.91M (+7.78%) | -11.05M (+0.09%) | -11.04M (+41.54%) | -7.80M (+11.11%) | -7.02M (+10.90%) | -6.33M (+39.43%) | -4.54M (+7.33%) | -4.23M (-2.76%) | -4.35M (+4.57%) | -4.16M (-0.95%) | -4.20M (+16.99%) | -3.59M |
Net Income | -6.95M (+16.22%) | -5.98M (-19.62%) | -7.44M (-12.98%) | -8.55M (-22.13%) | -10.98M (-7.50%) | -11.87M (-75.34%) | -48.13M (+114.39%) | -22.45M (+48.09%) | -15.16M (-3.13%) | -15.65M (+0.19%) | -15.62M (-3.88%) | -16.25M (+10.02%) | -14.77M (+2.78%) | -14.37M (+20.65%) | -11.91M (+7.78%) | -11.05M (+0.09%) | -11.04M (+41.54%) | -7.80M (+11.11%) | -7.02M (+10.90%) | -6.33M (+39.43%) | -4.54M (+7.33%) | -4.23M (-2.76%) | -4.35M (+4.57%) | -4.16M (-0.95%) | -4.20M (+16.99%) | -3.59M |
Comprehensive Income Net Of Tax | -28.92M (+383.61%) | -5.98M (-19.62%) | -7.44M (-12.98%) | -8.55M (-90.85%) | -93.47M (+688.78%) | -11.85M (-75.39%) | -48.16M (+114.43%) | -22.46M (-64.16%) | -62.66M (+300.90%) | -15.63M (0.00%) | -15.63M (-3.99%) | -16.28M (+10.22%) | -14.77M (+2.78%) | -14.37M (+20.65%) | -11.91M (+7.78%) | -11.05M (+0.09%) | -11.04M (+41.54%) | -7.80M (-64.75%) | -22.13M (+249.61%) | -6.33M (+39.43%) | -4.54M (+7.33%) | -4.23M (-74.06%) | -16.31M (+292.07%) | -4.16M (-0.95%) | -4.20M (+16.99%) | -3.59M |